The effect of pentoxifylline on the lung during cardiopulmonary bypass

European Journal of Cardio-thoracic Surgery

Volumn 10, Issue 5, 1996, Pages 339-346

  Turkoz R ^a,c   Yorukoglu K ^b   Akcay, A ^a   Yilik, L ^a   Baltalarli, A ^a   Karahan, N ^a   Adanir, T ^a   Sagban M ^a  

^a Izmir State Hospital   (Turkey)

^b 9th September University Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Cardiopulmonary bypass; Lung; Pentoxifylline

Indexed keywords

PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; FOREIGN BODY REACTION; HEMODYNAMICS; HUMAN; IMMUNOLOGY; LEUKOCYTE COUNT; LUNG; LUNG ALVEOLUS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NEUTROPHIL; PREMEDICATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE COUNT; VASCULAR RESISTANCE; VASCULARIZATION;

ADULT; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOREIGN-BODY REACTION; HEMODYNAMIC PROCESSES; HUMANS; LEUKOCYTE COUNT; LUNG; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NEUTROPHILS; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; PLATELET COUNT; PREMEDICATION; PULMONARY ALVEOLI; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR RESISTANCE;

EID: 0029690879     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)80092-3     Document Type: Article

References (41)

1. Andersen LW, Baek L. Thomsen BS, Rasmussen JP (1989) Effect of methyl-prednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth 3:544-549
2. Anyanwu E, Dittrich H, Gieseking R, Enders HJ (1982) Ultrastructural changes in the human lung following cardiopulmonary bypass. Basic Res Cardiol 77:309-322
3. Asada S, Yamaguchi M (1971) Fine structural change in the lung following cardiopulmonary bypass. Chest 59:478-483
4. Bessler H, Gilgal R, Djaldetti M, Zahavi I (1986) Effect of pentoxifylline on the phagocytic activity, cAMP levels and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 40: 747-754
5. Blauhut B, Gross C, Necek S, Doran JE, Späth P, Lundsgaard-Hansen P (1991) Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg 101:958-967
6. Butler J, Rocker GM, Westaby S (1993) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:552-559
7. Butler J, Baigrie RJ, Parker D, Chong JL, Shale DJ, Pillai R, Westaby S, Rocker GM (1993) Systemic inflammatory responses to cardiopulmonary bypass: a pilot study of the effects of pentoxifylline. Respir Med 87:285-288
8. Chandler DB, Hyde DM, Giri SN (1983) Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol 112:170-177
9. Chenoweth DE, Cooper SW, Hughi TE, Stewart RW, Blackstone EH, Kirklin JW (1981) Complement activation during cardiopulmonary bypass. N Engl J Med 304:497-503
10. Deng MC, Wiedner M, Erren M, Möllhoff T, Assmann G, Scheld G (1995) Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 9:22-29
11. Doerschuk CM, Winn RK, Coxon HO, Harlan JM (1990) CD 18-dependent and independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol 144:2327-2333
12. Edmuns LH, Ellison N, Colman RW, Niewiarowski S, Rao AK, Addonizio VP Jr, Stephenson LW, Edie RN (1982) Platelet function during cardiac operation: comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 83:805-812
13. Gibson RL, Redding GJ, Henderson WR, Troug WE (1991) Group B streptococcus induces tumor necrosis factor in neonatal piglets: effects of the tumor necrosis factor inhibitor pentoxifylline on hemodynamics and gas exchange. Am Rev Respir Dis 143:598-604
14. Gu YJ, Wang YS, Chiang BY, Gao XD, Ye CX, Wildevuur RH (1991) Reduction of granulocyte-mediated lung injury in canine cardiopulmonary bypass by anisomine infusion. Thorac Cardiovasc Surg 39:154-157
15. Hammerschmidt DE, Stroncek DF, Bowers TK, Lammi Keefe CJ, Kurth DM, Ozalins A, Nicoloff DM, Lillehei RC, Craddock PD, Jacob HS (1981) Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 81:370-377
16. Hammerschmidt DE, Kotasek D, McCarthy T, Huh P, Freyburger G, Vercelotti GM (1988) Pentoxifylline inhibits granulocyte and platelet function including granulocyte priming by platelet activating factor. J Lab Clin Med 112:254-263
17. Harker LA, Malpass TW, Bronson HE II, Slichter SJ (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 56:824-834
18. Harlan JM (1987) Neutrophil-mediated vascular injury. Acta Med Scand Suppl 715:123-129
19. Heidrich H, Paeprer M, Barckow D, Schartl M (1976) The effect of pentoxifylline on central and peripheral haemodynamics - an experimental clinical study. Z Kardiol 65:385-391
20. Howard RJ, Crain C, Franzini DA, Hood CI, Hugli TE (1988) Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation. Arch Surg 123:1496-1501
21. Jansen NJG, Van Oeveren W, Broek L van der, Oudemans-van Straaten HM, Stoutenbeek CP, Joen MC, Roozendaal KJ, Eysman L, Wildevuur CR (1991) Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 102:515-525
22. Kirklin JK (1989) The postperfusion syndrome: inflammation and the damaging effects of cardiopulmonary bypass. In: Tinker JH (ed) Cardiopulmonary bypass: current concepts and controversies. Saunders, Philadelphia, p 131
23. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86:845-857
24. Kongsgaard UE, Smith-Erichsen N, Geiran O, Amundsen E, Mollnes TE, Garred P (1989) Different activation patterns in the plasma kallikrein-kinin and complement systems during coronary bypass surgery. Acta Anaesthesiol Scand 33:343-347
25. McDonald RJ (1991) Pentoxifylline reduces injury to isolated lungs perfused with human neutrophils. Am Rev Respir Dis 144:1347-1350
26. Menasché P, Antebi H, Alcindor L, Teiger E, Perez G, Giudicelli Y, Nordmann R, Piwnica A (1990) Iron chelation by desferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans. Circulation 82 (Suppl IV):390-396
27. Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, Chow J, Ng Rp, Tse TF (1985) Warfarin versus dipyridamol-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. Circulation 72:1059-1063
28. Ohtani M, Matsuda H, Shirakura R, Sawa Y, Matsuwaka R, Kuki S, Nakano S, Kawashima Y (1988) Attenuation of pulmonary leukocyte sequestration during extracorporeal circulation by a new c-AMP phosphodiesterase inhibitor. ASAIO Trans 34:761-764
29. Rao RMK, Crawford J, Currie MS, Cohen HJ (1988) Actin depolymerization and inhibition of capping induced by pentoxifylline in human lymphocytes and neutrophils. J Cell Physiol 137:577-582
30. Ratliff NB, Young WG Jr, Hackel DB, Mikat E, Wilson JW (1973) Pulmonary injury secondary to extracorporeal circulation. J Thorac Cardiovasc Surg 65:425-432
31. Riegel W, Spillner G, Schlosser V, Horl WH (1988) Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 95:1014-1019
32. Root RK (1989) Leukocyte adhesion proteins: their role in neutrophil function. Trans Am Clin Climatol Assoc 101:207-224
33. Royston D, Fleming JS, Desai JB, Westaby S, Tayler KM (1986) Increased production of peroxidation products associated with cardiac operation: evidence for free radical generation. J Thorac Cardiovasc Surg 91:759-766
34. Schmalzer E, Chien S (1984) Filter-ability of subpopulation of leukocytes: Effect of pentoxifylline. Blood 64:542-546
35. Sole MJ, Drobac M, Schwartz L, Hussain MN, Vaughan-Neil EF (1979) The extraction of circulating catecholamines by the lungs in normal man and in patients with pulmonary hypertension. Circulation 60:160-163
36. Sullivan GW, Carper HT, Novick WL, Mandell GL (1988) Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 56:1722-1729
37. Tenneberg SD, Bailey WW, Cotta LA, Brodt JK, Solomkin JS (1986) The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass. Surgery 100:134-142
38. Van Oeveren W, Wildevuur CR (1987) Blood compatibility of cardiopulmonary bypass circuits. Perfusion 2:137-144
39. Van Oeveren W, Jansen NJG, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CR (1987) Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 44:640-645
40. Welsh CH, Lien D, Worthen GS, Weil JV (1988) Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. Am Rev Respir Dis 138:1106-1114
41. Zabel P, Schade FU (1994) Pentoxifylline and tumour necrosis factor-induced lung injury. Eur Respir J 7:1389-1391